It can take weeks to achieve results after restarting biologic treatments that were stopped, study shows.
Modern Medicine Feature Articles
Halobetasol propionate once a week for eight weeks in plaque psoriasis patients was effective, with no adverse events.
Long lauded for its ability to reduce the appearance of wrinkles, botulinum toxin is now being considered for reducing scarring.
The adoption of business concepts into medical practice creates challenges for physicians who have little business background. It places too much focus on the business of medicine and not enough on the practice of medicine.
Bronchial hyperreactivity associated with propranolol treatment for infantile hemangiomas may be due to age and low body weight, study shows.
Stress factors mothers experience before, during and soon after pregnancy can increase eczema risk in their children, according to a systematic review published Feb. 25, 2018 in The International Journal of Environmental Research and Public Health.
Changing the schedule of targeted therapies has been shown to improve the response rate in a mouse model of melanoma.
The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, accordint to a study published in the Journal of the American Academy of Dermatology.
A $78 single course of topical fluorouracil for keratinocyte carcinoma and actinic keratosis lesions, could lead to a savings in the hundreds of dollars in follow-up costs.
This study, which may have direct implications for treatment, explains why some actinic keratoses recur and progress after superficial destructive treatments — like cryotherapy.